Dive in

We have our own point of view on the people, technologies, and conversations that will shape the future.

Tag results
Portfolio
Clear all
List view Grid view
Filters
Squint factory AR

Squint Emerges From Menlo Labs With Funding From Sequoia and an Impressive Roster of Customers

Today, Squint revealed an impressive roster of customers that includes Volvo and Siemens, and announced $6 million in seed and pre-seed funding from Sequoia Arc, Menlo Ventures, and Menlo Labs.

Wave image generated by DALL-E
Generative AI: Lessons From Prior Waves
Anthropic graphic, square
Our Investment in Anthropic: The Foundation Layer for Generative AI
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
Our Investment in Luca: The AI-Driven Pricing Co-Pilot for Large E-commerce Companies
AI construction site graphic
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies
Ironman hero image

Pinecone Now Valued at $750M, Arguably the Most Important Element in the Modern Data Stack

Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.

Orb founders

Evolving Pricing and Scaling Revenue: Our Series A Investment in Orb

Nailing your monetization strategy has become more important than ever in today’s weakened macroeconomic climate, and it’s no longer as simple as charging per seat.

Video: Early Cancer Detection With Delfi
Video: Reengineering Drug Discovery With Recursion
Our Investment in Typeface: Generative AI at Enterprise Speed and Scale
Hat Trick: Menlo’s Third Investment in Finch in Three Years

Menlo’s Fintech Outlook for 2023

At Menlo Ventures, we’ve invested in fintech for a long time and, despite the volatility of the last two years, believe there’s still a lot to be excited about.

Back to Basics: Fundamentals for Building Breakout Consumer Companies
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna
Building the Organizational Knowledge Graph: Our Series B Investment in Sana
Squint Emerges From Menlo Labs With Funding From Sequoia and an Impressive Roster of Customers

Today, Squint revealed an impressive roster of customers that includes Volvo and Siemens, and announced $6 million in seed and pre-seed funding from Sequoia Arc, Menlo Ventures, and Menlo Labs.

June 1, 2023Greg Rudin
Generative AI: Lessons From Prior Waves

While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can help illuminate the path forward.

May 31, 2023Steve Sloane
Our Investment in Anthropic: The Foundation Layer for Generative AI

We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.

May 23, 2023Matt Murphy, Derek Xiao and Andreas Vandris
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics

Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.

May 2, 2023Greg Yap
Our Investment in Luca: The AI-Driven Pricing Co-Pilot for Large E-commerce Companies

Retail e-commerce is as old as the advent of the web. In the decades that followed, a wave of innovation across supply chain, logistics, advertising, payments, checkout, and storefront tech has vastly improved the consumer e-commerce experience.

April 28, 2023Aunkur Arya and Andreas Vandris
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies

OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history. The landmark achievement underscored the strength of generative AI’s pull in consumer markets—surpassing even the breakthroughs of the internet and smartphones.

April 27, 2023Shawn Carolan, Katie Keller and Derek Xiao
Pinecone Now Valued at $750M, Arguably the Most Important Element in the Modern Data Stack

Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.

April 27, 2023Tim Tully
Evolving Pricing and Scaling Revenue: Our Series A Investment in Orb

Nailing your monetization strategy has become more important than ever in today’s weakened macroeconomic climate, and it’s no longer as simple as charging per seat.

March 29, 2023Naomi Pilosof Ionita, Grace Ge and Katie Keller
Video: Early Cancer Detection With Delfi

Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.

March 9, 2023Greg Yap
Video: Reengineering Drug Discovery With Recursion

Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.

March 9, 2023Greg Yap, Johnny Hu and Ph.D.
Our Investment in Typeface: Generative AI at Enterprise Speed and Scale

Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.

February 27, 2023Matt Murphy and Derek Xiao
Hat Trick: Menlo’s Third Investment in Finch in Three Years

Congratulations to Jeremy Zhang, Ansel Parikh, and the Finch team on raising their Series B! For Menlo, it’s an exciting milestone, marking the third consecutive round we’ve invested in Finch.

February 22, 2023Croom Beatty
Menlo’s Fintech Outlook for 2023

At Menlo Ventures, we’ve invested in fintech for a long time and, despite the volatility of the last two years, believe there’s still a lot to be excited about.

February 15, 2023Aunkur Arya, Croom Beatty and Tyler Sosin
Back to Basics: Fundamentals for Building Breakout Consumer Companies

Economic downturns force us to get back to basics: The cost of new capital and low valuation multiples—even for top-performing public companies—force startups to make substantial progress per dollar to get a term sheet, much less an up round.

January 18, 2023Shawn Carolan and Katie Keller
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna

Cancer remains one of the leading causes of death in the U.S. and worldwide.

January 11, 2023Johnny Hu and Ph.D.
Building the Organizational Knowledge Graph: Our Series B Investment in Sana

There’s been a seismic shift in the environment for learning and training on the job.

December 13, 2022JP Sanday, Andreas Vandris and Weber Wong
loader.svg